ABL Diagnostics Announces UltraGene Respiratory Pathogens 21 After CE-IVD Registration by ABL SA Luxembourg
WOIPPY, FRANCE, July 27, 2026 /EINPresswire.com/ -- ABL Diagnostics (Euronext Paris – Compartiment B – ISIN : FR001400AHX6), a company specialized in molecular diagnostic solutions for infectious diseases, announces the commercial availability of …